Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06505512

A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index

A Study on the Significance of Joint Evaluation of Gastrointestinal Ultrasound Results and Renal Artery Resistance Index for Assessing the Intestinal-renal Syndrome in Sepsis Patients

Status
Recruiting
Phase
Study type
Observational
Enrollment
74 (estimated)
Sponsor
Zhangzhou Municipal Hospital · Academic / Other
Sex
All
Age
14 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In this study, the patients with sepsis caused by abdominal infection were divided into survival group and death group by ultrasound examination of gastrointestinal function, superior mesenteric artery blood flow, and renal artery resistance index. The cross-sectional area of gastric antrum, average time flow rate of superior mesenteric artery, colon diameter, colon peristalsis frequency, and renal artery resistance index of the two groups were compared to determine the progression of entero-renal syndrome as soon as possible. To provide reliable objective basis for clinical decision-making, in order to improve the success rate of rescue.

Detailed description

Adult patients admitted to EICU of our hospital who met the diagnostic criteria for sepsis were included in the study. Patients with intra-abdominal sepsis were divided into survival group and death group for case control. Exclusion criteria: open chest and abdomen injury, advanced tumor, uremia, pregnancy. The primary endpoint was survival. Extraction time: ICU (0h), ICU (6h, that is, after fluid resuscitation), ICU (24h), ICU (48h, 08:00 a.m.), ICU (72h, 08:00 a.m.), ICU (120h, 08:00 a.m.); Monitoring indicators: antral cross-section area, colon diameter, colon peristalsis frequency, renal artery resistance index, CVP, ScvO2, IL6, blood lactic acid, blood creatinine, fluid intake, bladder pressure. The primary endpoint of the study was survival rate, and statistical analysis was performed to evaluate the progression of enterorenal syndrome, provide reliable objective basis for subsequent clinical decision-making, and improve the success rate of rescue.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNo interventionNo intervention

Timeline

Start date
2024-01-19
Primary completion
2025-02-25
Completion
2025-03-31
First posted
2024-07-17
Last updated
2025-02-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06505512. Inclusion in this directory is not an endorsement.